Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CEBPA anticorps (AA 1-124)

CEBPA Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7147076
  • Antigène Voir toutes CEBPA Anticorps
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Épitope
    • 18
    • 14
    • 12
    • 9
    • 9
    • 8
    • 7
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-124
    Reactivité
    • 98
    • 78
    • 69
    • 8
    • 5
    • 5
    • 5
    • 5
    • 3
    • 3
    • 3
    • 1
    • 1
    Humain
    Hôte
    • 101
    • 4
    • 1
    • 1
    Lapin
    Clonalité
    • 96
    • 11
    Polyclonal
    Conjugué
    • 44
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CEBPA est non-conjugé
    Application
    • 65
    • 40
    • 19
    • 16
    • 15
    • 15
    • 10
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human CCAAT/enhancer-binding protein alpha protein (1-124AA)
    Isotype
    IgG
    Top Product
    Discover our top product CEBPA Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Autre désignation
    CEBPA (CEBPA Produits)
    Synonymes
    anticorps C/EBP-alpha, anticorps CEBP, anticorps C/ebpalpha, anticorps CBF-A, anticorps Cebp, anticorps DBPCEP, anticorps c/ebpa, anticorps cb1062, anticorps wu:fj20f03, anticorps C/EBP, anticorps C/EBPalpha, anticorps xC/EBP, anticorps cC/EBP, anticorps C/EBP alpha, anticorps CCAAT/enhancer binding protein alpha, anticorps CCAAT/enhancer binding protein (C/EBP), alpha, anticorps CCAAT/enhancer binding protein alpha L homeolog, anticorps CEBPA, anticorps Cebpa, anticorps cebpa, anticorps cebpa.L
    Sujet

    Background: Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5\\\'-T[TG]NNGNAA[TG]-3\\\' acting as an activator on distinct target genes (PubMed:11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Downregulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed:14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity).

    Aliases: Apoptotic cysteine protease antibody, Apoptotic protease Mch 5 antibody, C/EBP alpha antibody, C/ebpalpha antibody, CAP4 antibody, Caspase 8 precursor antibody, CBF-A antibody, CCAAT Enhancer Binding Protein alpha antibody, CCAAT/enhancer binding protein (C/EBP), alpha antibody, CCAAT/enhancer-binding protein alpha antibody, CEBP antibody, CEBP A antibody, CEBP alpha antibody, Cebpa antibody, CEBPA_HUMAN antibody, FADD homologous ICE/CED 3 like protease antibody, FADD like ICE antibody, FLICE antibody, ICE like apoptotic protease 5 antibody, ICE8 antibody, MACH antibody, MCH5 antibody, MORT1 associated CED 3 homolog antibody

    UniProt
    P49715
    Pathways
    Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Vous êtes ici:
Support technique